
Shankar Siva
@_shankarsiva
Radiation Oncologist at the Peter MacCallum Cancer Centre @petermaccc, Professor of Medicine, University of Melbourne, Australia 🇦🇺. Views are my own. #radonc
ID: 636619613
https://www.petermac.org/expert-finder/details/shankar-siva 16-07-2012 02:03:56
6,6K Tweet
8,8K Followers
848 Following

Having a toast or two to celebrate Sophia Kamran, MD 's promotion to Associate Professor at Harvard Medical School 🥂🥳 1️⃣st ever female Assoc Prof in a GU discipline at MGH 💪🔥 #clinicianscientist #leader #teacher #mentor #multitasker👩🍼🐕🐕🔬🩺 #glassceilingbreaker #needherscience


Pleased that Melbourne could be the only non-European city that contributed to this important study! #radonc Sandro Porceddu Mark Middleton OAM


Radiotherapy is not visible enough to patients—and what they don’t see, they may fear. It’s time to strengthen patient advocacy and engagement. Let’s make RT more transparent, accessible, and empowering. prof. Barbara Jereczek-Fossa final remarks #ESTRO25 #PatientEngagement #RTAwareness


Congrats to Dr Neil Wallace - rising above technical challenges to deliver a fantastic presentation at #ESTRO25 on the link between functional lung #RT dosimetry and clinical toxicity in patients with #lungcancer. 👏👏👏 Well done, Neil Wallace . Peter Mac Cancer Centre ESTRO



Published at the same time as this RCT demonstrating a reduction in pneumonitis from prehab in radiotherapy in #lungcancer. The evidence is building….. sciencedirect.com/science/articl… @btog British Thoracic Society (BTS) prehab4cancer Lung Cancer Nursing UK Lung Cancer Europe Cancer Research UK

🚨"Sharper Focus, Greater Comfort? Lessons From the ROBOMET Trial" - ascopubs.org/doi/10.1200/JC… I had a lot of fun with this editorial thanks 🙏 Journal of Clinical Oncology and edward chmiel Erin Gillespie, MD MPH Matthias Guckenberger #radonc

🔥⚡️🚀Great JCO editorial on the ROBOMET trial: SBRT didn’t improve pain at 1 month vs. conventional RT but showed more durable relief and a strong safety profile. Kudos to Chmiel, Matthias Guckenberger , Gillespie & Shankar Siva ! #RadiationOncology #SBRT #BoneMets OncoAlert


👀 - well, can it #lcsm peeps!!!??? CTSurgSocMedNetwork Elliot Servais, MD, FACS Biniam Kidane Tom Varghese Jr. MD, MS, MBA, FACS, MAMSE 🇺🇸 Brendon Stiles Jonathan Spicer MD PhD Drew Moghanaki Tim Kruser #radonc

🔊 New podcast episode out now! spotifycreators-web.app.link/e/XO1wBvzSoTb Shankar Siva joins Nick James also on @Prof-Nick-James.bsky.social Hoda Abdel-Aty 💙 to discuss SABR in Renal Cell Cancers ⚡ Innovative trial design 📈 Meaningful endpoints 🩻 Response assessment and advanced imaging 🤝 Collaboration is key

It’s always a pleasure to tour a superstar of #kidneycancer around Peter Mac Cancer Centre! 🤗 Welcome Daniel Heng! There was, of course, the obligatory breaking of bread with GU Cast | Urology podcast! 🤗


Very enjoyable podcast great work Hoda Abdel-Aty 💙 Nick James also on @Prof-Nick-James.bsky.social Shankar Siva. Superb overview of SABR in renal cancer, ambitious trials, challenging endpoints, how to engage surgeons (bribery and charm)


Today, we achieved a small milestone of registering the 100th prospective patient at Peter MacCallum Cancer Centre. Shankar Siva Melissa Barber Declan Murphy Peter Mac Radiation Oncology Peter Mac Cancer Centre irockregistry.com

📢This might just be THE DEFINITIVE meta-analysis of PSMA PET for #prostatecancer recurrence. 🚨Meta-analysis of 43 studies (n=8,119) ⬆️Sensitivity from 48% at PSA 0.2–0.5 ng/ml to >90% at PSA >2. Congrats Declan Murphy marlon perera + team European Association of Urology (EAU)! ➡️link shorturl.at/unfn5


☄️Neoadjuvant stereotactic ablative body radiotherapy for renal cell carcinoma (RCC) with thrombus: do, or do not? 👌Nice overview of the scarce data published by Jennifer Le Guévelou Laurence Albiges Shankar Siva and Karim Bensalah Paper online here 👇👇 sciencedirect.com/science/articl…
